{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "RPAY",
  "name": "Repay Holdings Corporation",
  "url": "https://orbyd.app/dossiers/RPAY/",
  "json_url": "https://orbyd.app/dossiers/RPAY.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "The takeout fight re-fired: Forager returned 2026-06-29 with $5.25 cash — 9% above the $4.80 the board killed in May — and was rejected again 2026-07-13, the same day the board seated a Parthenon-affiliated director under a cooperation agreement. At ~$3.88 the stock sits ~26% below a standing bid from a 12.4% holder that has now raised twice. Mid-August Q2, the first KUBRA quarter, is the next dated event.",
  "invalidation_trigger": "A weekly close below $3.45 gives back the entire re-rating off the revised-bid news and returns the tape to its pre-escalation $3.20–3.45 base; secondarily, Forager converting its 13D to a passive 13G or publicly withdrawing the $5.25 proposal removes the bid floor entirely.",
  "catalyst_date": "2026-08-11",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "semi-foundry-equipment"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "2026-07-13 board expansion from six to seven directors seating Zachary F. Sadek (Parthenon Capital Partners, PCP Managers L.P.) under a new cooperation agreement is a defensive consolidation — legacy sponsor votes locked alongside management.",
    "Watch for a third 13D as a cascade signal.",
    "2026-06-10 annual meeting: all directors held seats under plurality voting despite ~36-37% withhold, bottom ~1% of Russell 3000 director elections in the 2025-2026 season. Governance rebuke without board turnover.",
    "Balance sheet changed in June: KUBRA funded with a ~$600M Silver Point-led package ($500M senior secured term loan + $100M undrawn revolver), taking gross leverage to roughly 3x against ~$172M guided EBITDA. LBO math is materially worse than the April asset-light pitch.",
    "Q2 2026 print estimated ~2026-08-11 (Q2 2025 landed 2025-08-11) — first KUBRA-consolidated quarter. Binary on integration and organic growth quality; avoid fresh entries into the print unless the thesis is explicitly earnings-driven.",
    "Sizing discipline: special situations cap at ~2.5% gross even at best risk/reward. Oversized arb positions dilute a conviction book.",
    "Bid-to-market spread is the live sentiment gauge: $5.25 bid vs ~$3.88 tape = ~26% discount, i.e. the market assigns low deal probability. A narrowing spread without news means someone is accumulating.",
    "Analyst dispersion is wide: DA Davidson Buy PT $6.00 (reiterated post-rejection), UBS Neutral PT $4.25 (2026-06-03), five-analyst average ~$6.85. Treat the high targets as deal-contingent, not standalone DCF."
  ],
  "body_markdown": "## Current Thesis\nThe special situation that looked dead in late June has re-fired. Forager Capital Management submitted a revised all-cash proposal at $5.25 per share on 2026-06-29 — a 9% raise over the $4.80 the board rejected on 2026-05-04, and the second bid it has put on the table after losing every procedural round of the spring. The board rejected it unanimously on 2026-07-13, again calling it a significant undervaluation, with J.P. Morgan advising and Troutman Pepper Locke plus Sullivan & Cromwell on the legal side. On the same day it expanded from six to seven directors and seated Zachary F. Sadek, a senior partner at Parthenon Capital Partners — whose affiliate PCP Managers L.P. is one of the largest holders — under a new cooperation agreement. That is the tell on board intent: a friendly sponsor block formalized into a board seat one day after a raised bid. The stock re-rated off the June lows near $3.20 to a July high of $4.35, then faded to $3.88 by 2026-07-17. What an investor is buying here is not a payments growth story; it is a ~26% discount to a live cash bid from a 12.4% holder whose price has moved up, not down, through three months of rejection.\n\n## Bull Case\n- **The bid ladder is going the right way.** $4.80 (rejected 2026-05-04) → $5.25 (submitted 2026-06-29, rejected 2026-07-13). An activist that raises after losing a proxy vote is signalling committed capital, not a headline trade. The $5.25 level marks a 91% premium to the $2.75 30-day VWAP that prevailed when the original proposal landed.\n\n- **The 2026-06-10 vote is unresolved leverage.** All six directors kept their seats under plurality voting, but on a ~36-37% withhold — the bottom ~1% of 17,000-plus Russell 3000 director elections in the 2025-2026 season. Boards carrying that number into a second cycle have a thin defense.\n- **The discount to the standing bid is wide.** At $3.88 against a $5.25 proposal, the market prices roughly a one-in-four chance of a deal. DA Davidson's Peter Heckmann kept a Buy and a $6.00 target through the rejection; the five-analyst average sits near $6.85 versus a $342M market cap.\n- **Scale is genuinely larger post-KUBRA.** The 2026-06-01 close adds ~$150-154M of revenue and ~$27.5-30M of adjusted EBITDA over the back seven months, taking reach past 40% of U.S. and Canadian households and ~$130B in combined annual payment volume. FY26 is guided to $490-500M revenue and $168.5-176M adjusted EBITDA.\n\n## Bear Case\n- **The board has now said no twice and hardened its register.** Rejecting $5.25 while adding a sponsor-affiliated director under a cooperation agreement is a defense being built, not a process being run. Management language points at integrating KUBRA and \"executing on its strategic plan,\" which is the vocabulary of staying independent.\n- **Leverage rewrote the buyout math in June.** KUBRA was funded with a ~$600M Silver Point-led package — a $500M senior secured term loan plus a $100M undrawn revolver — putting gross leverage near 3x against ~$172M of guided EBITDA. A financial buyer now has to underwrite an already-levered balance sheet rather than the asset-light target Forager pitched in April.\n- **The underlying business is not growing.** TTM revenue of $312.73M is up ~1%, organic growth is guided at only 10-12%, and the FY26 jump to $490-500M is KUBRA consolidation, not demand. TTM net income of -$258.72M (-$3.08 EPS) reflects impairment, and UBS held Neutral with a $4.25 target on 2026-06-03.\n- **The tape is fading the escalation.** The stock has given back roughly 11% from the $4.35 July high and closed -4.43% on 2026-07-17. Post-rejection drift lower is how a market retires deal odds.\n- **Deal-contingent targets are not standalone value.** Strip the bid and the comparable is a sub-scale, 3x-levered bill-pay processor with mid-single-digit organic growth, which is a low-multiple asset — the June round-trip to $3.20 showed where that clears.\n\n## Setup & Price Structure\nPrice sits at $3.88 (2026-07-17) inside a 52-week range of $2.30 to $6.06 and a market cap of $341.78M. The June 5 low near $3.20 marked the post-annual-meeting capitulation; the revised-proposal news re-rated the name to $4.35 intraday in early July, and the 2026-07-13 rejection began the give-back. The live structure is a widening gap between a $5.25 cash proposal and a tape that will not hold $4.00 — the discount is the trade and also the warning. The $3.45 area is where the entire revised-bid move gets returned; below it the chart is back in the pre-escalation $3.20-3.45 base with no premium embedded. Above, $4.35 is the level a third raise or a tender would have to clear. Volume near 460k shares on the down day is unremarkable, so there is no visible distribution flush yet. Trend-following signals are noise here; the chart moves on 8-K headlines, and standard extension or moving-average rules should not be applied to this structure.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-08-11 (est.)** — Q2 2026 results, the first KUBRA-consolidated quarter (Q2 2025 landed 2025-08-11). The binary is whether organic growth ex-KUBRA holds double digits and whether integration costs pressure the $168.5-176M FY26 EBITDA guide. Entering a special-situation position into an earnings print that is not the thesis is the wrong risk.\n- **Ongoing, undated** — A third 13D filer. Two independent activists at ~21% invites a cascade; a new filer is the highest-value unscheduled event available.\n\n## Elapsed catalysts\n\n- **Ongoing, undated** — Forager's response to the 2026-07-13 rejection. A 13D/A, a further raise, or a move toward a consent solicitation or tender directly to holders would each reprice the name; silence past ~30 days reads as the campaign cooling. *(passed 27d ago)*\n- **Ongoing, undated** — Follow-through on the 2026-06-18 USDC-on-Stellar stablecoin proof-of-concept. The tape sold that announcement -6.2%; a named client or revenue attached to it would be the first evidence the pivot is more than a demo. *(passed 52d ago)*\n\n## What Would Change Our Mind\nThe read breaks on a weekly close below $3.45, which erases the re-rating that the $5.25 proposal produced and puts the stock back in its pre-escalation base with no deal premium priced. It also breaks on a process event rather than a price one: Forager converting its 13D to a passive 13G, publicly withdrawing the proposal, or letting a full quarter pass without escalation would confirm the board has outlasted the campaign. On the other side, the setup upgrades materially if Forager raises a third time, launches a tender or consent solicitation, or if a third activist files a 13D — any of those turns a ~26% discount into a process with a clock. A Q2 print in mid-August that shows KUBRA integration slipping or organic growth below the 10-12% guide would remove the fundamental floor that makes the activists' valuation argument credible in the first place.\n\n## Correlation Notes\nThis trades on its own event calendar, not on payments-sector beta. Correlation to FIS, FISV and GPN is weak while a bid is outstanding; the relevant comparison set is other sub-$500M-cap activist-targeted processors and the broader small-cap take-private tape, which is sensitive to credit spreads — a widening high-yield market makes a levered buyout of an already 3x-levered target harder to finance. The KUBRA-driven utility and government bill-pay exposure adds a slow, defensive revenue base uncorrelated to consumer discretionary volumes. Nothing in the stablecoin proof-of-concept currently justifies grouping this with crypto-payment names; the 2026-06-18 reaction showed the market declining to pay for that association.",
  "first_seen": "2026-04-20",
  "last_analyzed": "2026-07-19T11:29:52+00:00",
  "last_synthesized": "2026-07-19",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}